Dianthus Therapeutics, Inc.

DNTH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
424B5 Aug 18, 2022 424B5
4 Aug 17, 2022 FORM 4 SUBMISSION
3 Aug 17, 2022 FORM 3 SUBMISSION
8-K Aug 17, 2022 8-K
EFFECT Aug 12, 2022
CORRESP Aug 10, 2022
UPLOAD Aug 9, 2022
S-3 Aug 4, 2022 S-3
10-Q Aug 4, 2022 10-Q
8-K Aug 4, 2022 8-K
4 Aug 1, 2022 FORM 4 SUBMISSION
4 Aug 1, 2022 FORM 4 SUBMISSION
4 Aug 1, 2022 FORM 4 SUBMISSION
4 Aug 1, 2022 FORM 4 SUBMISSION
4 Aug 1, 2022 FORM 4 SUBMISSION
4 Aug 1, 2022 FORM 4 SUBMISSION
4 Aug 1, 2022 FORM 4 SUBMISSION
4 Aug 1, 2022 FORM 4 SUBMISSION
4 Jun 30, 2022 FORM 4 SUBMISSION
4 Jun 30, 2022 FORM 4 SUBMISSION
4 Jun 30, 2022 FORM 4 SUBMISSION
4 Jun 30, 2022 FORM 4 SUBMISSION
4 Jun 30, 2022 FORM 4 SUBMISSION
4 Jun 30, 2022 FORM 4 SUBMISSION
4 Jun 30, 2022 FORM 4 SUBMISSION
← Newer Page 14 of 27 · 661 filings Older →